DAX+1,41 % EUR/USD-0,28 % Gold+0,57 % Öl (Brent)-2,05 %

Omnicell and Huron to Provide Outcome-Based Professional Services

Nachrichtenquelle: Business Wire (engl.)
09.12.2019, 14:01  |  101   |   |   

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, is partnering with Huron, a global professional services firm, to provide project implementation and change management services for customers adopting Omnicell technology.

Today’s healthcare systems are challenged to leverage data and technology to optimize operations, improve clinical outcomes, and deliver a more consumer-centric healthcare experience. Yet, according to a study by the IT Research firm, The Standish Group, only 29 percent of healthcare IT projects are considered to be successful.1

Recognizing the complexity of technology and the importance of a seamless implementation and integration experience, Omnicell has engaged Huron to provide customers dedicated expertise to drive faster adoption of their technology solutions and achieve better clinical and financial outcomes.

“The growing complexity of healthcare technology means greater opportunity for mishaps, pitfalls, and mismanagement,” said Scott Seidelmann, executive vice president and chief commercial officer at Omnicell. “Omnicell has made this decision to help our customers manage these complexities through proper project planning, direction, and governance structure that deliver, comprehensive outcomes-based success.”

Huron’s experts will apply best practices and recommend a change management plan best suited for each unique engagement. Huron will provide project management and implementation support to enable adoption and align communication and governance with desired business outcomes.

“As healthcare organizations and pharmacies increase the use of technology to improve the patient experience and clinical outcomes, ensuring adoption is critical,” said Allen Zimmerman, managing director and pharmacy expert in Huron’s healthcare business. “We are excited to work with Omnicell to align resources and deliver improved outcomes.”

Professional Services are a key pillar of autonomous pharmacy, a roadmap to develop a zero error, fully automated medication management infrastructure. Leveraging automation, data intelligence, and expert services, the autonomous pharmacy will empower pharmacists, nurses, clinicians, and pharmacy staff to focus on patient and clinician satisfaction.

About Huron

Huron is a global consultancy that helps our clients drive growth, enhance performance and sustain leadership in the markets they serve. We partner with them to develop strategies and implement solutions that enable the transformative change our clients need to own their future. Learn more at www.huronconsultinggroup.com.

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and expert services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 6,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.

1The Standish Group International, Inc. CHAOS Report 2015. https://www.standishgroup.com/sample_research_files/CHAOSReport2015-Fi ...

OMCL-G

Omnicell Aktie jetzt für 4€ handeln - auf Smartbroker.de



Diesen Artikel teilen
Wertpapier

Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
NASDAQ


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel

Diskussionen zu den Werten

ZeitTitel
07.03.19